Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 5 | 140633982 | upstream gene variant | T/C;G | snv |
|
Infections | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 5 | 140634318 | upstream gene variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.080 | 5 | 140634318 | upstream gene variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.120 | 5 | 140635623 | upstream gene variant | G/C | snv | 0.27 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.120 | 5 | 140635623 | upstream gene variant | G/C | snv | 0.27 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.160 | 5 | 140634792 | upstream gene variant | C/A;T | snv |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.160 | 5 | 140634792 | upstream gene variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.160 | 5 | 140634792 | upstream gene variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.160 | 5 | 140631883 | synonymous variant | C/A;G | snv | 4.8E-05; 9.3E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.160 | 5 | 140631883 | synonymous variant | C/A;G | snv | 4.8E-05; 9.3E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.160 | 5 | 140633722 | upstream gene variant | G/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.160 | 5 | 140633722 | upstream gene variant | G/A;T | snv |
|
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.882 | 0.160 | 5 | 140633722 | upstream gene variant | G/A;T | snv |
|
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.882 | 0.160 | 5 | 140633722 | upstream gene variant | G/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.160 | 5 | 140633722 | upstream gene variant | G/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.851 | 0.200 | 5 | 140631730 | 3 prime UTR variant | C/A | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.200 | 5 | 140631730 | 3 prime UTR variant | C/A | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.200 | 5 | 140631730 | 3 prime UTR variant | C/A | snv | 0.26 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.200 | 5 | 140631730 | 3 prime UTR variant | C/A | snv | 0.26 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.620 | 0.560 | 5 | 140633331 | intron variant | A/G | snv | 0.57 |
|
Stomatognathic Diseases | 0.030 | 0.667 | 3 | 2016 | 2019 | |||||||
|
0.620 | 0.560 | 5 | 140633331 | intron variant | A/G | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.620 | 0.560 | 5 | 140633331 | intron variant | A/G | snv | 0.57 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 1.000 | 2 | 2014 | 2015 | |||||||
|
0.620 | 0.560 | 5 | 140633331 | intron variant | A/G | snv | 0.57 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.620 | 0.560 | 5 | 140633331 | intron variant | A/G | snv | 0.57 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2009 | 2019 | |||||||
|
0.620 | 0.560 | 5 | 140633331 | intron variant | A/G | snv | 0.57 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |